ArticleJournal of biomedical informatics2021
A novel deep interval type-2 fuzzy LSTM (DIT2FLSTM) model applied to COVID-19 pandemic time-series prediction.
Article in Journal of biomedical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Machine Learning Techniques Applied to COVID-19 Prediction: A Systematic Literature Review.Bioengineering (Basel, Switzerland) · 2025Review
- Interval type-2 Fuzzy control and stochastic modeling of COVID-19 spread based on vaccination and social distancing rates.Computer methods and programs in biomedicine · 2023Article
- Nesting the SIRV model with NAR, LSTM and statistical methods to fit and predict COVID-19 epidemic trend in Africa.BMC public health · 2023Article
- A data-driven hybrid ensemble AI model for COVID-19 infection forecast using multiple neural networks and reinforced learning.Computers in biology and medicine · 2022Article
- Novel informatics approaches to COVID-19 Research: From methods to applications.Journal of biomedical informatics · 2022Article
- Interval type-2 fuzzy computational model for real time Kalman filtering and forecasting of the dynamic spreading behavior of novel Coronavirus 2019.ISA transactions · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, the novel COVID-19 coronavirus has been widely spread as a global pandemic. The COVID-19 pandemic has a major influence on human life, healthcare systems, and the economy. There are a large number of methods available for predicting the incidence of the virus. A complex and non-stationary problem such as the COVID-19 pandemic is characterized by high levels of uncertainty in its behavior during the pandemic time. The fuzzy logic, especially Type-2 Fuzzy Logic, is a robust and capable model to cope with high-order uncertainties associated with non-stationary time-dependent features. The main objective of the current study is to present a novel Deep Interval Type-2 Fuzzy LSTM (DIT2FLSTM) model for prediction of the COVID-19 incidence, including new cases, recovery cases, and mortality rate in both short and long time series. The proposed model was evaluated on real datasets produced by the world health organization (WHO) on top highly risked countries, including the USA, Brazil, Russia, India, Peru, Spain, Italy, Iran, Germany, and the U.K. The results confirm the superiority of the DIT2FLSTM model with an average area under the ROC curve (AUC) of 96% and a 95% confidence interval of [92-97] % in the short-term and long-term. The DIT2FLSTM was applied to a well-known standard benchmark, the Mackey-Glass time-series, to show the robustness and proficiency of the proposed model in uncertain and chaotic time series problems. The results were evaluated using a 10-fold cross-validation technique and statistically validated through the t-test method. The proposed DIT2FLSTM model is promising for the prediction of complex problems such as the COVID-19 pandemic and making strategic prevention decisions to save more lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.